<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Acta Naturae</journal-id><journal-title-group><journal-title xml:lang="en">Acta Naturae</journal-title><trans-title-group xml:lang="ru"><trans-title>Acta Naturae</trans-title></trans-title-group></journal-title-group><issn publication-format="print">2075-8251</issn><publisher><publisher-name xml:lang="en">Acta Naturae Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">10769</article-id><article-id pub-id-type="doi">10.32607/20758251-2010-2-3-72-77</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>Articles</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>Статьи</subject></subj-group><subj-group subj-group-type="article-type"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title xml:lang="en">Association of ERAP1 Allelic Variants with Risk of Ankylosing Spondylitis</article-title><trans-title-group xml:lang="ru"><trans-title>Association of ERAP1 Allelic Variants with Risk of Ankylosing Spondylitis</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name><surname>Zvyagin</surname><given-names>I V</given-names></name><email>izvyagin@gmail.com</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name><surname>Dorodnykh</surname><given-names>V Yu</given-names></name><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name><surname>Mamedov</surname><given-names>I Z</given-names></name><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name><surname>Staroverov</surname><given-names>D B</given-names></name><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name><surname>Bochkova</surname><given-names>A G</given-names></name><xref ref-type="aff" rid="aff2"/></contrib><contrib contrib-type="author"><name><surname>Rebrikov</surname><given-names>D V</given-names></name><xref ref-type="aff" rid="aff3"/></contrib><contrib contrib-type="author"><name><surname>Lebedev</surname><given-names>Y B</given-names></name><xref ref-type="aff" rid="aff5"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">Shemyakin and Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences</institution></aff><aff><institution xml:lang="ru"></institution></aff></aff-alternatives><aff-alternatives id="aff2"><aff><institution xml:lang="en">Institute of Rheumatology, Russian Academy of Medical Sciences</institution></aff><aff><institution xml:lang="ru"></institution></aff></aff-alternatives><aff-alternatives id="aff3"><aff><institution xml:lang="en">Vavilov Institute of General Genetics, Russian Academy of Sciences</institution></aff><aff><institution xml:lang="ru"></institution></aff></aff-alternatives><aff-alternatives id="aff4"><aff><institution xml:lang="en">DNA-Technology JSC</institution></aff><aff><institution xml:lang="ru"></institution></aff></aff-alternatives><aff id="aff5"><institution>Shemyakin and Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences</institution></aff><pub-date date-type="pub" iso-8601-date="2010-09-15" publication-format="electronic"><day>15</day><month>09</month><year>2010</year></pub-date><volume>2</volume><issue>3</issue><issue-title xml:lang="en">VOL 2, NO3 (2010)</issue-title><issue-title xml:lang="ru">ТОМ 2, №3 (2010)</issue-title><fpage>72</fpage><lpage>77</lpage><history><date date-type="received" iso-8601-date="2020-01-17"><day>17</day><month>01</month><year>2020</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2010, Zvyagin I.V., Dorodnykh V.Y., Mamedov I.Z., Staroverov D.B., Bochkova A.G., Rebrikov D.V., Lebedev Y.B.</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2010, Zvyagin I.V., Dorodnykh V.Y., Mamedov I.Z., Staroverov D.B., Bochkova A.G., Rebrikov D.V., Lebedev Y.B.</copyright-statement><copyright-year>2010</copyright-year><copyright-holder xml:lang="en">Zvyagin I.V., Dorodnykh V.Y., Mamedov I.Z., Staroverov D.B., Bochkova A.G., Rebrikov D.V., Lebedev Y.B.</copyright-holder><copyright-holder xml:lang="ru">Zvyagin I.V., Dorodnykh V.Y., Mamedov I.Z., Staroverov D.B., Bochkova A.G., Rebrikov D.V., Lebedev Y.B.</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">https://creativecommons.org/licenses/by/4.0</ali:license_ref></license></permissions><self-uri xlink:href="https://actanaturae.ru/2075-8251/article/view/10769">https://actanaturae.ru/2075-8251/article/view/10769</self-uri><abstract xml:lang="en"><p/></abstract><trans-abstract xml:lang="ru"><p>Ankylosing spondylitis (AS) belongs to a group of autoimmune diseases affecting the axial skeleton. Beside the hla-b*27 allele, several other human genes that control the variety processes of immune homeostasis are considered to be associated with AS manifestation in different human populations. Among strong associated non-MHC genes erap 1 encoding the endoplasmic reticulum aminopeptidase 1 isoform was recently identified by single nucleotide polymorphisms (SNPs) meta analysis. In our study we inspected the genetic association of five non-synonymous coding SNPs from erapl with AS in Caucasians. We implemented the SSP-PCR system for precise genotyping of 87 hla-b*27 positive AS patients and 77 hla-b*27 healthy donors from the Russian population. Considerable differences in allele’s frequencies within patients vs control cohort were shown for 3 of 5 SNPs under investigation. Using the EM-algorhitm we reconstructed 3-marker haplotypes that distinguish with high probability two cohorts due to differences in the haplotypes frequencies. In such a way both the sensitive, CCT, haplotype and the protective, TTC, one were predicted. To verify the calculation we determined genuine frequencies of 5-marker haplotypes in AS cohort by haplotyping of individual cDNA samples using improved SSP-PCR primer set. We demonstrated that the frequencies of in silica reconstucted haplotypes and the frequencies of experimentally detected haplotypes are in a good agreement. Frequency of the risk haplotype CCT (rs17482078/10050860/2287987) detected within AS cohort reaches 88%, as well as the frequency calculated by EM-algorhitm.</p></trans-abstract><kwd-group xml:lang="en"><kwd>aminopeptidase ERAP1</kwd><kwd>human single nucleotide polymorphism</kwd><kwd>allele-specific PCR</kwd><kwd>human haplotypes</kwd><kwd>ankylosing spondylitis</kwd></kwd-group></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>van der Linden S.M., Valkenburg H.A., de Jongh B.M., Cats A. // Arthritis Rheum. 1984. V. 27. N 3. P. 241-249.</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Pedersen O.B., Svedensen A.J., Ejstrup L., et al. // Scand. J. Rheumatol. 2008. V. 37. N 2. P. 120-126.</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Brown M.A., Laval S.H., Brophy S., Calin A. // Ann. Rheum. Dis. 2000. V. 59. N 11. P. 883-886.</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Reveille J.D., Maganti R.A. // Adv. Exp. Med. Biol. 2009. V. 649. P. 159-176.</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>The Australo-Anglo-American Spondyloarthritis Consortium (TASC) // Nature Genetics. 2010. V. 42. No 2. P. 123-127.</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Wellcome Trust Case Control Consortium &amp; The Australo-Anglo-American Spondylitis Consortium (TASC) // Nature Genetics. 2007. V. 39. N 11. P. 1329-1337.</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Toshihiro T., Hattori A., Shinako M., et al. // J. Biol. Chem. 2003. V. 278. N 34. P. 32275-32283.</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>Cui X., Hawari F., Alsaaty S., et al. // J. Clin. Invest. 2002. V. 110. N 4. P. 515-526.</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>Cui X., Rouhani N.F., Hawari F., et al. // J. Immunology. 2003. V. 171. N 12. P. 6814-6819.</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>Cui X., Rouhani N.F., Hawari F., Levine J.S. // J. Biol. Chem. 2003. V. 278. P. 28677-28685.</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>Harvey D., Pointon J.J., Evans M.D., et al. // Hum. Mol. Genet. 2009. V. 18. N 21. P. 4204-4212.</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>Choi C.-B., Kim T.-H., Jun J.-B., et al. // Ann. Rheum. Dis. 2010. V. 69. N 3. P. 582-584.</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation>Tsui F.W.L., Haroon N., Reveille D.J., et al. // Ann. Rheum. Dis. 2010. V. 69. N 4. P. 733-736.</mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation>Maksymowych W.P., Inman R.D., Gladman D.D., et al. // Arthr. &amp; Rheum. 2009. V. 60. N 5. P. 1317-1323.</mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation>Pazar B., Safrani E., Gergely P., et al. // J. Rheum. 2010. V. 37. N 2. P. 379-384.</mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation>Haroon N., Inman D.R. // Nat. Rev. Rheum. 2010. Advanced online publication.</mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation>Wigginton J., Cutler D., Abecasis G.A. // Am. J. Hum. Genet. 2005. V. 76. N 5. P. 887-883.</mixed-citation></ref><ref id="B18"><label>18.</label><mixed-citation>Gabriel S.B., Schaffner S.F., Nguyen H., et al. // Science. 2002. V. 296. N 5576. P. 2225-2229.</mixed-citation></ref><ref id="B19"><label>19.</label><mixed-citation>Goto Y., Hattori A., Ishii Y., Tsujimoto M. // FEBS Lett. 2006. V. 580. P. 1833-1838.</mixed-citation></ref><ref id="B20"><label>20.</label><mixed-citation>Kamphausen E., Kellert C., Abbas T., et al. // Cancer Immun. Immunother. 2010. V. 59. N 8. P. 1273-1284.</mixed-citation></ref></ref-list></back></article>
